You are here

580b57fcd9996e24bc43c53e   LinkedIn Logo 500x500   Facebook logo square   Iguana Trans cropped

event icon
Date
07.10.19 - 08.10.19
John McIntyre Conference Centre, The University of Edinburgh, Pollock Halls, 18 Holyrood Par

A British Pharmacological Society event


Overview

Stem cell derived therapies are complex and diverse, so it is critical that we understand the challenges faced in getting clinical trials for these therapies approved.

Across two days, we will discuss how some therapies have made progress towards clinical trials, particularly in relation to assessing safety. We will also look at areas where new technologies can fill vital gaps, such as in combination therapies with smart materials.

This meeting will be of particular interest to pharmacologists, those working in toxicology, clinicians, academics and industry. Regulators, including MHRA and FDA, will also be joining our panel discussions.

Hear from leaders in the field including Pete Coffey, Agnete Kirkeby, Martin Pera, Kevin Eggan, David Hay, Richard Adair, Sarah Waters and our key note speaker, Jane Lebkowski.

Contact

For further details and to register please visit the event webpage

Continuing Professional Development (CPD)

This event is approved by the Royal Society of Biology for purposes of CPD and may be counted as 42 CPD credits.

We use cookies: to perform functions such as login and account management; and to track usage with Google analytics to improve our website. To find out more about the cookies we use and how to delete them, see our cookie policy.   I accept cookies from this site.